SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMediumNeutral
Announced Wed, 13 Aug · 20:01 IST

Shilpa Medicare Limited has informed Intimation of submission of Application for Reclassification of Promoter/ Promoter Group from Promoter Group category to "Public category, pursuant to Regulation 31A (8) (c) of SEBI (LODR), Regulations, 2015

Promoter Stake Sell 1pctOwnership Changes View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shilpa Medicare has applied to BSE and NSE on 13th August 2025 to reclassify two members of its Promoter Group — Suraj Kumar Inani and Priya Inani — from the 'Promoter Group' category to the 'Public' category, under SEBI LODR Regulation 31A(8)(c). Together, these two individuals hold 40,01,391 shares, which is 4.09% of the company's paid-up capital (Suraj Kumar Inani: 39,20,695 shares or 4.01%; Priya Inani: 80,696 shares or 0.08%). The exchanges will now review and approve the reclassification. If approved, these shares will no longer count as promoter group holdings and will instead be treated as public shareholding.

Likely market impact

If approved, the company's public float will increase by about 4.09%, which can improve liquidity and may be viewed positively by investors who prefer a higher free float. However, the effective promoter group stake will correspondingly shrink, which some investors may read as a mild dilution of promoter influence in the company.